期刊文献+

Deficiency of anti-inflammatory cytokine IL-4 leads to neural hyperexcitability and aggravates cerebral ischemia-reperfusion injury 被引量:3

原文传递
导出
摘要 Systematic administration of anti-inflammatory cytokine interleukin 4(IL-4)has been shown to improve recovery after cerebral ischemic stroke.However,whether IL-4 affects neuronal excitability and how IL-4 improves ischemic injury remain largely unknown.Here we report the neuroprotective role of endogenous IL-4 in focal cerebral ischemia-repertusion(I/R)injury.In multi-electrode array(MEA)recordings,IL-4 reduces spontaneous firings and network activities of mouse primary cortical neurons.IL-4 mRNA and protein expressions are upregulated after I/R injury.Genetic deletion of 11-4 gene aggravates I/R injury in vivo and exacerbates oxygen-glucose deprivation(OGD)injury in cortical neurons.Conversely,supplemental IL-4 protects 11-4-/-cortical neurons against OGD injury.Mechanistically,cortical pyramidal and stellate neurons common for ischemic penumbra after I/R injury exhibit intrinsic hyperexcitability and enhanced excitatory synaptic transmissions in Il-4-/-mice.Furthermore,upregulation of Nav1.1 channel,and downregulations of KCa3.1 channel and a6 subunit of GABAA receptors are detected in the cortical tissues and primary cortical neurons from Il-4-/-mice.Taken together,our findings demonstrate that IL-4 deficiency results in neural hyperexcitability and aggravates I/R injury,thus activation of IL-4 signaling may protect the brain against the development of permanent damage and help recover from ischemic injury after stroke.
出处 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2020年第9期1634-1645,1802,共13页 药学学报(英文版)
基金 supported by research grants from the National Natural Science Foundation of China(81573410) the National Science and Technology Major Project(2018ZX09711001-004006,China) the Natural Sciences Foundation of Shandong Province(ZR2015QL008,China)awarded to Kewei Wang
  • 相关文献

参考文献3

二级参考文献31

  • 1Turner, R.C.; Dodson, S.C.; Rosen, C.L.; Huber, J.D.J. Neurosurg. 2013, 118, 1072-1085.
  • 2Fisher, M.; Feuerstein, G.; Howells, D.W.; Hum, ED.; Kent, T.A.; Savitz, S.I.; Lo, E.H. Stroke. 2009, 40, 2244- 2250.
  • 3Lo, E.H.; Dalkam, T.; Moskowitz, M.A. Nat. Re~. Neurosci. 2003, 4, 399-415.
  • 4Lee, W.T.; Lin, M.H.; Lee, E.J.; Hung, Y.C.; Tai, S.H.; Chen, H.Y.; Chen, T.Y.; Wu, T.S. PloS One. 2012, 7, e39952.
  • 5Chen, Y.H.; Huang, P.H.; Lin, F.Y.; Chen, W.C.; Chen, Y.L.; Yin, W.H.; Man, K.M.; Liu, EL. Eur. J. Integ. Med. 2011, 3, e317-e324.
  • 6Liang, C.J.; Lee, C.W.; Sung, H.C.; Chen, Y.H.; Wang, S.H.; Wu, P.J.; Chiang, Y.C.; Tsai, J.S.; Wu, C.C.; Li, C.Y.; Chen, Y.L. Am. J. Chin. Med. 2014, 42, 619-637.
  • 7Huang, X.; Wang, C.; Chen, K.; Xiang, T.; Hart, Z. Chin. J. Neuroimmunol. Neurol. 2007, 14, 118-119.
  • 8Lin, Y.R.; Chen, H.H.; Ko, C.H.; Chan, M.H. Eur. J. Pharmacol. 2006, 53 7, 64-69.
  • 9Pyo, M.K.; Lee, Y.; Yun-Choi, H.S. Arch. Pharmacol. Res. 2002, 25, 325-328.
  • 10Yan, Y.; Lin, Q.; Xu, Y.; Huang, X. Chin. J. Exp. Tradit. Med. Formul. 2011, 17, 223-225.

共引文献20

同被引文献39

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部